Dopaminergic therapy prescribed to address motor symptoms in Parkinson’s disease (PD) is done at the expense of some cognition functions. It has been hypothesized that whether a given function is improved or impaired by medication depends on the baseline dopamine levels within underlying brain regions. Areas most affected by PD and severely dopamine depleted are predicted to benefit from dopaminergic therapy. Regions with less dopamine deficiency are predicted to worsen from excessive dopamine stimulation. This theoretical framework is known as the dopamine overdose hypothesis. The central aim of this thesis was to critically test the straightforward predictions put forward by this overdose account. First, I examined the effects of dopamine...
Emerging evidence suggests that dopamine may modulate learning and memory with important implication...
L-dopa is the most commonly prescribed drug for the treatment of Parkinson’s disease (PD). Most pati...
BACKGROUND: Dopaminergic therapy proved to ameliorate motor deficits in Parkinson's disease but its ...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
OBJECTIVE: The aim was to examine the effect of dopaminergic medication on stimulus-response learnin...
The primary aim of the research I have undertaken is to better understand the influence of dopamine ...
Parkinson's disease (PD) is commonly treated with dopaminergic medication, which enhances some, whil...
Parkinson’s disease (PD) is characterized by resting tremor, rigidity, and bradykinesia. Dopaminergi...
Cognitive abnormalities are a feature of Parkinson\u27s disease (PD). Unlike motor symptoms that are...
Cognitive dysfunction is a feature of Parkinson\u27s Disease (PD). Some cognitive functions are impa...
IntroductionPatients with Parkinson’s disease (PD) exhibit deficits in social cognition, particularl...
Parkinson’s disease (PD) is characterized by resting tremor, rigidity and bradykinesia. Dopaminergic...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson’s...
We investigated the hypothesis that variation in endogenous dopamine (DA) across brain regions expla...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Emerging evidence suggests that dopamine may modulate learning and memory with important implication...
L-dopa is the most commonly prescribed drug for the treatment of Parkinson’s disease (PD). Most pati...
BACKGROUND: Dopaminergic therapy proved to ameliorate motor deficits in Parkinson's disease but its ...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
OBJECTIVE: The aim was to examine the effect of dopaminergic medication on stimulus-response learnin...
The primary aim of the research I have undertaken is to better understand the influence of dopamine ...
Parkinson's disease (PD) is commonly treated with dopaminergic medication, which enhances some, whil...
Parkinson’s disease (PD) is characterized by resting tremor, rigidity, and bradykinesia. Dopaminergi...
Cognitive abnormalities are a feature of Parkinson\u27s disease (PD). Unlike motor symptoms that are...
Cognitive dysfunction is a feature of Parkinson\u27s Disease (PD). Some cognitive functions are impa...
IntroductionPatients with Parkinson’s disease (PD) exhibit deficits in social cognition, particularl...
Parkinson’s disease (PD) is characterized by resting tremor, rigidity and bradykinesia. Dopaminergic...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson’s...
We investigated the hypothesis that variation in endogenous dopamine (DA) across brain regions expla...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Emerging evidence suggests that dopamine may modulate learning and memory with important implication...
L-dopa is the most commonly prescribed drug for the treatment of Parkinson’s disease (PD). Most pati...
BACKGROUND: Dopaminergic therapy proved to ameliorate motor deficits in Parkinson's disease but its ...